4//SEC Filing
PAREKH RAJESH B 4
Accession 0001104659-21-067516
CIK 0001035354other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 9:22 AM ET
Size
7.7 KB
Accession
0001104659-21-067516
Insider Transaction Report
Form 4
PAREKH RAJESH R
Director
Transactions
- Purchase
Common Stock
2021-05-13$1.35/sh+84,776$114,448→ 171,807 total(indirect: See footnote) - Purchase
Common Stock
2021-05-13$1.35/sh+2,381,890$3,215,552→ 4,827,129 total(indirect: See footnote)
Footnotes (3)
- [F1]Reflects the purchase of shares in the offering of Common Stock of Eloxx Pharmaceuticals, Inc. that is expected to close on May 18, 2021.
- [F2]Held directly by Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP. The Reporting Person disclaims beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein.
- [F3]Held directly by Advent Life Sciences Fund II LP. Advent Life Sciences LLP is the manager of Advent Life Sciences Fund II LP and the Reporting Person is a general partner of Advent Life Sciences LLP. The Reporting Person disclaims beneficial ownership of the reported shares, except to the extent of any pecuniary interest therein.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001429930
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 9:22 AM ET
- Size
- 7.7 KB